Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

30.95 -0.14 (-0.45%)
Streaming Delayed Price Updated: 12:17 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) announced better-than-expected revenue in Q2 CY2025, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s revenue guidance... 
Via StockStory
Earnings Scheduled For July 31, 2025
 
Via Benzinga
Earnings To Watch: Omnicell (OMCL) Reports Q2 Results Tomorrow
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Earnings Scheduled For May 6, 2025
 
Via Benzinga
Why Omnicell (OMCL) Stock Is Trading Up Today
Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 3.3% in the afternoon session after an analyst at Wells Fargo raised the firm's price target on the stock and maintained an "Overweight"... 
Via StockStory
Topics ETFs Stocks World Trade
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
3 Cash-Heavy Stocks Facing Headwinds
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,... 
Via StockStory
Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Omnicell (NASDAQ:OMCL) and the... 
Via StockStory
1 Cash-Producing Stock with Promising Prospects and 2 to Keep Off Your Radar
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
1 Small-Cap Stock to Research Further and 2 to Brush Off
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports,... 
Via StockStory
Topics Government Stocks World Trade
What Analysts Are Saying About Omnicell Stock
 
Via Benzinga
Why Omnicell (OMCL) Stock Is Trading Up Today
Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 5.9% in the afternoon session after the company reported impressive preliminary second quarter 2025 and full-year profit guidance due to... 
Via StockStory
Topics Artificial Intelligence World Trade
Advance Auto Parts Posts Upbeat Results, Joins Domo, LiveRamp, Urban Outfitters And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
OMCL Q1 Earnings Call: Revenue Tops Expectations but Tariff Headwinds Pressure Profit Outlook
Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s revenue... 
Via StockStory
Topics Economy World Trade
3 Russell 2000 Stocks Walking a Fine Line
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
3 Hated Stocks Skating on Thin Ice
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
 
Via Benzinga
2 Healthcare Stocks with Promising Prospects and 1 to Think Twice About
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
Beyond The Numbers: 4 Analysts Discuss Omnicell Stock
 
Via Benzinga
Why Omnicell (OMCL) Shares Are Trading Lower Today
Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 17.5% in the afternoon session after the company reported weak first-quarter 2025 results, which featured full-year EPS and EBITDA guidance... 
Via StockStory
Topics Artificial Intelligence
Omnicell’s (NASDAQ:OMCL) Q1 Sales Top Estimates But Stock Drops
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s... 
Via StockStory
Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results tomorrow morning. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and... 
Via StockStory
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and... 
Via StockStory
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings?
What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many shareholders. This was partly driven by its softer quarterly results and may have... 
Via StockStory
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.